Use of oxycodone in pain treatment in a metastatic prostate cancer patient: case study

Wojciech Leppert; Sebastian Werner

eISSN: 2081-2833
ISSN: 2081-0016

Medycyna Paliatywna/Palliative Medicine

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

1/2012
vol. 4

Send email

Copy url:

abstract:

Clinical research

Use of oxycodone in pain treatment in a metastatic prostate cancer patient: case study

Wojciech Leppert

,

Sebastian Werner

Medycyna Paliatywna 2012; 1: 37–40

Online publish date: 2012/05/22

View full text Get citation

In this paper we report a 65-year-old man diagnosed with disseminated prostate cancer with numerous bone metastases and neuropathic pain component. In this patient controlled-release (CR) oxycodone provided effective analgesia without adverse effects. Former pain treatment was ineffective due to too low doses of transdermal buprenorphine and lack of the use of adjuvant analgesics. The treatment with CR oxycodone was effective and well tolerated for the period of one year and it is still continued.

keywords:

Use of oxycodone in pain treatment in a metastatic prostate cancer patient: case study

Wojciech Leppert , Sebastian Werner

analgesia, pain, oxycodone, prostate cancer, opioid switch

Wojciech Leppert

,

Sebastian Werner